Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
2.890
+0.180 (6.64%)
At close: Feb 25, 2025
ASE:HPIC Balance Sheet
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | - | 7.25 | 6.63 | 7.73 | 5.86 | Upgrade
|
Cash & Short-Term Investments | 7.97 | 7.25 | 6.63 | 7.73 | 5.86 | Upgrade
|
Cash Growth | 9.97% | 9.39% | -14.23% | 31.91% | 85.30% | Upgrade
|
Accounts Receivable | - | 9.67 | 9.34 | 7.44 | 10.11 | Upgrade
|
Other Receivables | - | 0.05 | 0.05 | 0.02 | 0.03 | Upgrade
|
Receivables | - | 9.71 | 9.39 | 7.46 | 10.13 | Upgrade
|
Inventory | - | 3.59 | 3.61 | 3.24 | 2.79 | Upgrade
|
Prepaid Expenses | - | 0.1 | 0.09 | 0.03 | 0.03 | Upgrade
|
Other Current Assets | - | 0.58 | 0.43 | 0.54 | 0.44 | Upgrade
|
Total Current Assets | - | 21.24 | 20.16 | 18.99 | 19.26 | Upgrade
|
Property, Plant & Equipment | - | 12.93 | 13.68 | 14.04 | 13.36 | Upgrade
|
Long-Term Investments | - | 0 | 0 | 0 | 0 | Upgrade
|
Long-Term Deferred Charges | - | 0.24 | 0.18 | - | - | Upgrade
|
Total Assets | - | 34.4 | 34.01 | 33.04 | 32.61 | Upgrade
|
Accounts Payable | - | 1.08 | 1.44 | 0.99 | 2.37 | Upgrade
|
Accrued Expenses | - | 0.63 | 0.58 | 0.5 | 0.91 | Upgrade
|
Short-Term Debt | - | 0.08 | 0.41 | 0.53 | - | Upgrade
|
Current Portion of Long-Term Debt | - | 0.4 | 0.76 | 0.73 | 0.73 | Upgrade
|
Current Income Taxes Payable | - | 0.36 | 0.46 | 0.5 | 0.46 | Upgrade
|
Other Current Liabilities | - | 1.07 | 0.98 | 0.75 | 0.23 | Upgrade
|
Total Current Liabilities | - | 3.62 | 4.62 | 4.01 | 4.7 | Upgrade
|
Long-Term Debt | - | 1.46 | 0.03 | 0.82 | 1.44 | Upgrade
|
Total Liabilities | - | 5.08 | 4.64 | 4.82 | 6.14 | Upgrade
|
Common Stock | - | 9.5 | 9.5 | 9.5 | 9.5 | Upgrade
|
Retained Earnings | - | 19.82 | 19.87 | 18.72 | 16.97 | Upgrade
|
Shareholders' Equity | 28.88 | 29.32 | 29.37 | 28.22 | 26.47 | Upgrade
|
Total Liabilities & Equity | - | 34.4 | 34.01 | 33.04 | 32.61 | Upgrade
|
Total Debt | 3.58 | 1.94 | 1.19 | 2.08 | 2.17 | Upgrade
|
Net Cash (Debt) | 4.39 | 5.31 | 5.44 | 5.65 | 3.69 | Upgrade
|
Net Cash Growth | -17.34% | -2.28% | -3.69% | 53.13% | 117.63% | Upgrade
|
Net Cash Per Share | 0.46 | 0.56 | 0.57 | 0.59 | 0.39 | Upgrade
|
Filing Date Shares Outstanding | 9.5 | 9.5 | 9.5 | 9.5 | 9.83 | Upgrade
|
Total Common Shares Outstanding | 9.5 | 9.5 | 9.5 | 9.5 | 9.83 | Upgrade
|
Working Capital | - | 17.62 | 15.54 | 14.99 | 14.56 | Upgrade
|
Book Value Per Share | 3.04 | 3.09 | 3.09 | 2.97 | 2.69 | Upgrade
|
Tangible Book Value | 28.88 | 29.32 | 29.37 | 28.22 | 26.47 | Upgrade
|
Tangible Book Value Per Share | 3.04 | 3.09 | 3.09 | 2.97 | 2.69 | Upgrade
|
Land | - | 1.88 | 1.88 | 1.88 | 1.88 | Upgrade
|
Buildings | - | 6.58 | 6.56 | 6.23 | 5.66 | Upgrade
|
Machinery | - | 10.52 | 10.31 | 9.76 | 8.3 | Upgrade
|
Construction In Progress | - | 0.12 | 0.01 | 0.2 | 0.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.